Codexis (CDXS) Total Debt (2017 - 2026)

Codexis (CDXS) recorded quarterly Total Debt of $40.5 million in Q1 2026, up 0.94% quarter-over-quarter from $40.1 million in Q4 2025, and up 38.71% on a YoY basis from $29.2 million in Q1 2025.

Codexis (CDXS) Total Debt (2017 - 2026) Analysis & Trends

Codexis' Total Debt history runs 5 years deep, the most recent figure standing at $40.5 million for Q1 2026.

  • In Q1 2026, Total Debt rose 38.71% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (up 38.71% YoY), while the FY2025 annual figure was $40.1 million, up 38.75% from the prior year.
  • Total Debt was $40.5 million for Q1 2026 at Codexis, up from $40.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $40.5 million in Q1 2026 to a low of $28.1 million in Q1 2024.
  • Historically, Total Debt has averaged $33.7 million across 3 years, with a median of $29.2 million in 2025.
  • Biggest YoY gain for Total Debt was 38.81% in 2025; the steepest drop was 3.86% in 2025.
  • A 3-year view of Total Debt shows it stood at $28.9 million in 2024, then soared by 38.75% to $40.1 million in 2025, then advanced by 0.94% to $40.5 million in 2026.
  • The last three Total Debt figures came in at $40.5 million (Q1 2026), $40.1 million (Q4 2025), and $39.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 319.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn 40.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.48 Mn
Dec 31, 2025 40.11 Mn
Sep 30, 2025 39.73 Mn
Jun 30, 2025 39.37 Mn
Mar 31, 2025 29.19 Mn
Dec 31, 2024 28.91 Mn
Sep 30, 2024 28.63 Mn
Jun 30, 2024 28.37 Mn
Mar 31, 2024 28.10 Mn
Sep 30, 2018 122,000.00
Jun 30, 2018 183,000.00
Mar 31, 2018 243,000.00
Dec 31, 2017 302,000.00
Sep 30, 2017 360,000.00
Jun 30, 2017 419,000.00
Mar 31, 2017 255,000.00